5N Plus has delivered extremely strong long term returns. With the stock now around US$32, the key issue for anyone looking at it today is whether that price can be justified by the company’s earnings power.
For investors, the debate is whether 5N Plus's current share price is adequately backed by the earnings it is generating today and is expected to produce over time.
If you are weighing whether 5N Plus at around US$32 fairly reflects its earnings, it can help to compare it with other companies screened for 6 high quality undervalued stocks.
The P/E ratio suits 5N Plus because earnings are a key focus for a business built around long term contracts and margin management. On this measure, the stock trades at about 35.3x earnings. That sits below the chemicals industry average of roughly 17.2x but also below a peer group sitting nearer 42.6x, so the market is already attaching a premium to the sector while still pricing 5N Plus at a lower multiple than some direct comparables.
Given the fair P/E level implied by the valuation framework is lower than the current 35.3x, the shares screen as overvalued on this earnings yardstick. Because 2025 and 2026 results brought higher profits alongside pressure on input costs, the recent strength in reported income does not fully offset the fact that the price is already well ahead of what the model suggests for a stock with this risk and return profile. Despite renewed optimism after strong 2025 numbers and confirmed 2026 guidance, the P/E multiple still asks you to pay up for 5N Plus relative to what the tailored benchmark would point to. Explore the numbers behind 5N Plus's P/E valuation.
Simply Wall St Narratives pick up where the 5N Plus valuation puzzle leaves off and spell out which paths for revenue, profitability and earnings would need to hold for the stock to be worth much more or much less than today’s price. Each Narrative treats 5N Plus' implied worth as a thesis about the business that you can watch over time, rather than a single frozen snapshot. They live on the Simply Wall St Community page.
One of the top narratives on 5N Plus: 42% undervalued
This Narrative is the bullish analyst Narrative on Simply Wall St, built on the most optimistic analyst price target and forecasts, not one person's view.
"The current valuation implies the share price does not fully reflect record Specialty Semiconductors revenue, progress toward the high end of 2026 adjusted EBITDA guidance and the multi year pipeline…"
Discover why this Narrative puts 5N Plus at 42% undervalued.
Beyond earnings and valuation, Simply Wall St's broader checks have highlighted specific risk factors for 5N Plus that are important to weigh before forming a view. Take a closer look at 1 major warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com